Phase I study of the somatostatin analogue somatuline in refractory small-cell lung carcinoma.
Cotto
C
C
Quoix
E
E
Thomas
F
F
Henane
S
S
Trillet-Lenoir
V
V
D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010456:Peptides, Cyclic; D013004:Somatostatin / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D015282:Octreotide